| Nursing mothers should avoid supplemental N-Acetylcysteine and should only be used by
pregnant women if prescribed by a physician. N-Acetylcysteine clearance is reduced in
individuals with chronic liver disease as well as in pre-term newborns. NAC may be harmful
if it is administered early in the treatment of critically ill patients. NAC may intensify
headaches in those taking nitrates to treatment angina. Although the incidence of cystine
renal stones is low, they do occur. Those who do form renal stones should avoid NAC
supplements. NAC and its sulfhydryl metabolites could produce a false-positive result in the
nitroprusside test for ketone bodies used in diabetes. N-Acetylcysteine should be used with
caution in those with a history of peptic ulcer disease, since mucolytic agents may disrupt
the gastric mucosal barrier. Adverse reactions reported with oral NAC include diarrhea,
headache (especially when used along with nitrates), nausea, rashes, and vomiting. There are
rare reports of renal stone formation. Adverse reactions reported with intravenous NAC
include bronchospasm, chills, fever, headache, nausea, rashes, rhinorrhea, stomatitis,
tinnitus, urticaria, and vomiting. There are also some rare reports of anaphylactic
reactions. Common symptoms of those experiencing anaphylactoid reactions are angioedema,
bronchospasm, ECG change, flushing, hypertension, hypotension, nausea, pruritis, rash,
tachycardia, and vomiting. The anaphylactoid reactions are pseudo-allergic. Using
supplemental NAC with nitrates can cause headaches. Using supplemental NAC with
carbamazepine can cause reduced serum levels of carbamazepine. This website is intended to
educate and inform, and should not replace discussions with your doctor. |